Spurious Drug Factory Busted In Gandhinagar

Ahmedabad: The Gujarat Food and Drug Administration (FDCA) raided a factory operating illegally within the Gujarat Industrial Development Corporation (GIDC) estate in Gandhinagar. The unit, owned by Bhavin Patel, was making medicines with a licence. The authorities suspect the factory was supplying “substandard and potentially harmful drugs across the state”, a press release from Gujarat FDCA said.

Gujarat FDCA commissioner H G Koshia said the raid unearthed a web of irregularities. Patel allegedly used fake production licences and did not have a qualified technician on the staff. Investigators suspect tablet fillers such as dibasic calcium phosphate (DCP) or starch were being used with no or improper active pharmaceutical ingredients (APIs) in medication that was sold as azithromycin, paracetamol, methylcobalamin (a vitamin B12 drug), pregabalin (analgesic) and thiocolchicoside (rheumatism drug).

“We found that they had replaced methylcobalamin, pregabalin and thiocolchicoside with DCP, starch or cheaper APIs and sold these spurious medicines. We have taken samples and are filing a case against them,” Koshia said.

Patel allegedly obtained fake production licences and GSTIN/UIN to set up the factory. “He procured the machinery to make tablets and capsules and had even secured a bank loan. Dummy pellets, empty capsule shells, omeprazole capsules, omeprazole pellets and maize starch powder were found at the factory,” Koshia added. The raid led to seizures of machinery, packaging material and counterfeit APIs, worth about Rs 4 crore.

Raw materials and finished products valued at Rs 43 lakh were also seized, the Gujarat FDCA statement said.

Related Posts

Kerala HC upholds DC’s move against vague discount boards; dismisses chemists’ petitions

In a landmark judgment, the High Court of Kerala has validated the state Drugs Control Department’s regulatory action targeting deceptive advertising and vague discount boards outside retail pharmacy outlets. The…

Stakeholders push for stronger supply chain compliance through GSDP training

In a significant move to strengthen India’s pharmaceutical supply chain and safeguard patient safety, regulators, industry representatives, academia, and the cold chain community have jointly emphasized the urgent need to…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Kerala HC upholds DC’s move against vague discount boards; dismisses chemists’ petitions

Kerala HC upholds DC’s move against vague discount boards; dismisses chemists’ petitions

Stakeholders push for stronger supply chain compliance through GSDP training

Stakeholders push for stronger supply chain compliance through GSDP training

India’s Battle Against Addiction: From Liquor Ban To ‘Dry Drugs’, Bihar’s Youth Trapped In A Growing Narcotics Crisis

India’s Battle Against Addiction: From Liquor Ban To ‘Dry Drugs’, Bihar’s Youth Trapped In A Growing Narcotics Crisis

Ovarian Reserve is ‘Jumping Age’ in Indian Women, SHE Delhi red flags

Ovarian Reserve is ‘Jumping Age’ in Indian Women, SHE Delhi red flags

8 Women Develop Complications Post C-Section, 2 Critical

8 Women Develop Complications Post C-Section, 2 Critical

Kota District In-Charge Secretary Directs Implementation of Risk Management Framework in Hospitals; Emphasis on SOPs and Infection Control

Kota District In-Charge Secretary Directs Implementation of Risk Management Framework in Hospitals; Emphasis on SOPs and Infection Control